ID   L-428 KS
AC   CVCL_X206
SY   L 428 KS; L428 KS; L428KS
DR   Wikidata; Q54900868
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2690233;
RX   PubMed=6303739;
CC   Population: Caucasian.
CC   Characteristics: Adapted to growth in calf serum (PubMed=2690233; PubMed=6303739).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Gly112_Val122del11 (c.334_366del33); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1361 ! L-428
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 13
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001).
//
RX   PubMed=2690233; DOI=10.1007/978-3-642-83781-4_5;
RA   Schaadt M., Burrichter H., Pfreundschuh M., Schell-Frederick E.,
RA   Tesch H., Fonatsch C., Stein H., Diehl V.;
RT   "Biology of Hodgkin cell lines.";
RL   Recent Results Cancer Res. 117:53-61(1989).
//
RX   PubMed=6303739; DOI=10.1055/s-2008-1069671;
RA   Kirchner H.H., Burrichter H., Stein H., Fonatsch C., Schaadt M.,
RA   Ziegler A., Heit W., Diehl V.;
RT   "Properties of Hodgkin cell lines. Possible significance for
RT   pathophysiology and clinical medicine.";
RL   Dtsch. Med. Wochenschr. 108:936-944(1983).
//